Characterization of heart disease in mucopolysaccharidosis type II mice.
Tavares AMV, Gonzalez EA, Viana IS, Visioli F, Vera LNP, Baldo G.
Cardiovasc Pathol. 2023 Nov-Dec;67:107575. doi: 10.1016/j.carpath.2023.107575. Epub 2023 Sep 18.
Mucopolysaccharidosis-Plus Syndrome.
Vasilev F, Sukhomyasova A, Otomo T.
Int J Mol Sci. 2020 Jan 9;21(2):421. doi: 10.3390/ijms21020421.
Glycosaminoglycans in mucopolysaccharidoses and other disorders.
Khan SA, Nidhi F, Leal AF, Celik B, Herreño-Pachón AM, Saikia S, Benincore-Flórez E, Ago Y, Tomatsu S.
Adv Clin Chem. 2024;122:1-52. doi: 10.1016/bs.acc.2024.06.011. Epub 2024 Jul 23.
The Costello syndrome.
Say B, Güçsavaş M, Morgan H, York C.
Am J Med Genet. 1993 Aug 15;47(2):163-5. doi: 10.1002/ajmg.1320470203.
Diagnosis and Management of Mucopolysaccharidosis Type II (Hunter Syndrome) in Poland.
Żuber Z, Kieć-Wilk B, Kałużny Ł, Wierzba J, Tylki-Szymańska A.
Biomedicines. 2023 Jun 8;11(6):1668. doi: 10.3390/biomedicines11061668.
Progressive heart disease in mucopolysaccharidosis type I mice may be mediated by increased cathepsin B activity.
Baldo G, Tavares AM, Gonzalez E, Poletto E, Mayer FQ, Matte UD, Giugliani R.
Cardiovasc Pathol. 2017 Mar-Apr;27:45-50. doi: 10.1016/j.carpath.2017.01.001. Epub 2017 Jan 6.
Emerging drugs for the treatment of mucopolysaccharidoses.
Giugliani R, Federhen A, Vairo F, Vanzella C, Pasqualim G, da Silva LM, Giugliani L, de Boer AP, de Souza CF, Matte U, Baldo G.
Expert Opin Emerg Drugs. 2016;21(1):9-26. doi: 10.1517/14728214.2016.1123690. Epub 2016 Jan 9.
Pre-operative Considerations in Adult Mucopolysaccharidosis Patients Planned for Cardiac Intervention.
Cross B, Stepien KM, Gadepalli C, Kharabish A, Woolfson P, Tol G, Jenkins P.
Front Cardiovasc Med. 2022 Apr 4;9:851016. doi: 10.3389/fcvm.2022.851016. eCollection 2022.
Diagnostic and treatment strategies in mucopolysaccharidosis VI.
Vairo F, Federhen A, Baldo G, Riegel M, Burin M, Leistner-Segal S, Giugliani R.
Appl Clin Genet. 2015 Oct 30;8:245-55. doi: 10.2147/TACG.S68650. eCollection 2015.
Non-cardiac Manifestations in Adult Patients With Mucopolysaccharidosis.
Stepien KM, Bentley A, Chen C, Dhemech MW, Gee E, Orton P, Pringle C, Rajan J, Saxena A, Tol G, Gadepalli C.
Front Cardiovasc Med. 2022 Mar 7;9:839391. doi: 10.3389/fcvm.2022.839391. eCollection 2022.
